Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 16.

Blagojevic, J; Bellando-Randone, S; Abignano, G; Avouac, J; Cometi, L; Czirják, L; Denton, C P; Distler, O; Frerix, M; Guiducci, S; Huscher, D; Jaeger, V K; Lóránd, V; Maurer, B; Nihtyanova, S; Riemekasten, G; Siegert, E; Tarner, I H; Vettori, S; Walker, U A; Allanore, Y; Müller-Ladner, U; Del Galdo, F; Matucci-Cerinic, M; EUSTAR co-workers (2019). Classification, categorization and essential items for digital ulcer evaluation in systemic sclerosis: a DeSScipher/European Scleroderma Trials and Research group (EUSTAR) survey. Arthritis Research & Therapy, 21(1):35.

Maurer, B (2013). Frühsymptome der Dermatomyositis und des Antisynthetase-Syndroms. Zeitschrift für Rheumatologie, 72(10):970-976.

Avouac, J; Palumbo, K; Tomcik, M; Zerr, P; Dees, C; Horn, A; Maurer, B; Akhmetshina, A; Beyer, C; Sadowski, A; Schneider, H; Shiozawa, S; Distler, O; Schett, G; Allanore, Y; Distler, J H W (2012). Inhibition of AP-1 signaling abrogates TGF-ß mediated activation of fibroblasts and prevents experimental fibrosis. Arthritis and Rheumatism, 64(5):1642-1652.

Winklehner, A; Berger, N; Maurer, B; Distler, O; Alkadhi, H; Frauenfelder, T (2012). Screening for interstitial lung disease in systemic sclerosis: the diagnostic accuracy of HRCT image series with high increment and reduced number of slices. Annals of the Rheumatic Diseases, 71(4):549-552.

Distler, J H W; Strapatsas, T; Huscher, D; Dees, C; Akhmetshina, A; Kiener, H P; Tarner, I H; Maurer, B; Walder, M; Michel, B; Gay, S; Smolen, J S; Müller-Ladner, U; Schett, G; Distler, O (2011). Dysbalance of angiogenic and angiostatic mediators in patients with mixed connective tissue disease. Annals of the Rheumatic Diseases, 70(7):1197-1202.

Kohler, Georg (2010). Begriffe der Moderne. In: Albrecht, J; Kohler, G; Maurer, B. Expansion der Moderne. Zürich: gta Verlag, 25-38.

Imhof, K (2010). Das Böse. Zur Weltordnung des Kalten Krieges. In: Albrecht, J; Kohler, G; Maurer, B. Expansion der Moderne. Zürich: gta Verlag, 81-104.

Maurer, B; Stanczyk, J; Jüngel, A; Akhmetshina, A; Trenkmann, M; Brock, M; Kowal-Bielecka, O; Gay, R E; Michel, B A; Distler, J H W; Gay, S; Distler, O (2010). MicroRNA-29, a key regulator of collagen expression in systemic sclerosis. Arthritis and Rheumatism, 62(6):1733-1743.

Reich, N; Maurer, B; Akhmetshina, A; Venalis, P; Dees, C; Zerr, P; Palumbo, K; Zwerina, J; Nevskaya, T; Gay, S; Distler, O; Schett, G; Distler, J H W (2010). The transcription factor Fra-2 regulates the production of extracellular matrix in systemic sclerosis. Arthritis and Rheumatism, 62(1):280-290.

Albrecht, J; Kohler, Georg; Maurer, B (2010). Vorwort: Expansion der Moderne. In: Albrecht, J; Kohler, G; Maurer, B. Expansion der Moderne. Zürich: gta Verlag, 9-10.

Venalis, P; Maurer, B; Akhmetshina, A; Busch, N; Dees, C; Stürzl, M; Zwerina, J; Jüngel, A; Gay, S; Schett, G; Distler, O; Distler, J H W (2009). Lack of inhibititory effects of the anti-fibrotic drug imatinib on endothelial cell functions in vitro and in vivo. Journal of Cellular and Molecular Medicine, 13(10):4185-4191.

Hemmatazad, H; Maciejewska Rodrigues, H; Maurer, B; Brentano, F; Pileckyte, M; Distler, J H W; Gay, R E; Michel, B A; Gay, S; Huber, L C; Distler, O; Jüngel, A (2009). Histone deacetylase 7, a potential target for the antifibrotic treatment of systemic sclerosis. Arthritis and Rheumatism, 60(5):1519-1529.

Maurer, B; Walder, M; Gay, R E; Gay, S; Distler, O (2009). Systemische Sklerose: Zielkriterien der Behandlung. Zeitschrift für Rheumatologie, 68(1):37-43.

Maurer, B; Busch, N; Jüngel, A; Pileckyte, M; Gay, R E; Michel, B A; Schett, G; Gay, S; Distler, J; Distler, O (2009). Transcription factor Fos-Related Antigen-2 induces progressive peripheral vasculopathy in mice closely resembling human systemic sclerosis. Circulation, 120(23):2367-2376.

Akhmetshina, A; Dees, C; Pileckyte, M; Maurer, B; Axmann, R; Jüngel, A; Zwerina, J; Gay, S; Schett, G; Distler, O; Distler, J H W (2008). Dual inhibition of c-abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis. FASEB Journal, 22(7):2214-2222.

Maurer, B; Distler, J H W; Moritz, F; Gay, S; Distler, O (2007). Angiogenese – therapeutische Interventionsmöglichkeiten bei rheumatischen Erkrankungen. Zeitschrift für Rheumatologie, 66(4):304-310.

This list was generated on Wed Jun 26 14:04:50 2019 CEST.